Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00379613
Status:
COMPLETED
Last Update Posted:
2017-08-22
First Post:
2006-09-21
Brief Title:
Use of Sugammadex Administered at 5 Minutes After Administration of 12 mgkg Esmeron 194205P05942
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-11-07
Start Date Type:
ACTUAL
Primary Completion Date:
2004-07-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-07-14
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-21
First Submit QC Date:
September 21 2006
Study First Post Date:
2006-09-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-18
Last Update Post Date:
2017-08-22
Last Update Post Date Type:
ACTUAL